 Cory Christiansen
Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Limbs | 28 | 2025 | 180 | 8.890 |
Why?
| | Amputees | 18 | 2025 | 85 | 5.700 |
Why?
| | Gait | 22 | 2024 | 280 | 5.640 |
Why?
| | Walking | 34 | 2025 | 500 | 5.620 |
Why?
| | Arthroplasty, Replacement, Knee | 13 | 2025 | 306 | 4.040 |
Why?
| | Exercise | 17 | 2025 | 1928 | 3.380 |
Why?
| | Exercise Therapy | 13 | 2025 | 412 | 3.030 |
Why?
| | Osteoarthritis, Knee | 12 | 2025 | 240 | 2.820 |
Why?
| | Tibia | 10 | 2024 | 172 | 2.590 |
Why?
| | Lower Extremity | 17 | 2025 | 408 | 2.390 |
Why?
| | Veterans | 13 | 2025 | 1375 | 2.350 |
Why?
| | Movement | 12 | 2025 | 270 | 2.240 |
Why?
| | Walk Test | 7 | 2024 | 70 | 2.100 |
Why?
| | Biomechanical Phenomena | 26 | 2025 | 764 | 1.700 |
Why?
| | Disabled Persons | 3 | 2020 | 140 | 1.700 |
Why?
| | Middle Aged | 70 | 2025 | 31136 | 1.610 |
Why?
| | Aged | 57 | 2025 | 22061 | 1.610 |
Why?
| | Femur | 6 | 2025 | 243 | 1.570 |
Why?
| | Torso | 6 | 2021 | 31 | 1.550 |
Why?
| | Osteoarthritis, Hip | 3 | 2024 | 43 | 1.540 |
Why?
| | Telerehabilitation | 4 | 2025 | 36 | 1.520 |
Why?
| | Muscle Strength | 8 | 2024 | 303 | 1.470 |
Why?
| | Knee Joint | 10 | 2025 | 374 | 1.470 |
Why?
| | Multiple Sclerosis | 5 | 2024 | 438 | 1.440 |
Why?
| | Self-Management | 3 | 2024 | 163 | 1.420 |
Why?
| | Disability Evaluation | 7 | 2023 | 285 | 1.340 |
Why?
| | Recovery of Function | 11 | 2025 | 642 | 1.320 |
Why?
| | Weight-Bearing | 8 | 2024 | 162 | 1.290 |
Why?
| | Parkinson Disease | 8 | 2025 | 461 | 1.290 |
Why?
| | Accelerometry | 6 | 2025 | 93 | 1.250 |
Why?
| | Resilience, Psychological | 2 | 2021 | 126 | 1.200 |
Why?
| | Telemedicine | 4 | 2025 | 792 | 1.190 |
Why?
| | Health Behavior | 5 | 2024 | 743 | 1.130 |
Why?
| | Self Efficacy | 3 | 2020 | 377 | 1.100 |
Why?
| | Activities of Daily Living | 6 | 2024 | 382 | 1.100 |
Why?
| | Range of Motion, Articular | 13 | 2025 | 367 | 1.080 |
Why?
| | Male | 63 | 2025 | 63671 | 1.060 |
Why?
| | Humans | 96 | 2025 | 129627 | 1.000 |
Why?
| | Prosthesis Design | 5 | 2024 | 309 | 0.940 |
Why?
| | Female | 62 | 2025 | 68735 | 0.930 |
Why?
| | Hip Joint | 6 | 2025 | 158 | 0.920 |
Why?
| | Muscle, Skeletal | 7 | 2025 | 1613 | 0.910 |
Why?
| | Joints | 1 | 2025 | 101 | 0.880 |
Why?
| | Single-Blind Method | 6 | 2024 | 271 | 0.870 |
Why?
| | Cross-Sectional Studies | 16 | 2023 | 5075 | 0.870 |
Why?
| | Biofeedback, Psychology | 3 | 2025 | 35 | 0.870 |
Why?
| | Mobility Limitation | 3 | 2018 | 61 | 0.840 |
Why?
| | Aged, 80 and over | 19 | 2021 | 7052 | 0.830 |
Why?
| | Osseointegration | 9 | 2025 | 60 | 0.770 |
Why?
| | Arthroplasty, Replacement, Hip | 3 | 2024 | 137 | 0.760 |
Why?
| | Pelvis | 2 | 2020 | 104 | 0.740 |
Why?
| | Exercise Test | 9 | 2024 | 613 | 0.740 |
Why?
| | Resistance Training | 1 | 2024 | 151 | 0.740 |
Why?
| | Physical Therapy Modalities | 5 | 2020 | 294 | 0.730 |
Why?
| | Accidental Falls | 3 | 2020 | 169 | 0.710 |
Why?
| | Mechanical Phenomena | 1 | 2020 | 83 | 0.640 |
Why?
| | Prosthesis Implantation | 7 | 2024 | 146 | 0.620 |
Why?
| | Teriparatide | 1 | 2018 | 6 | 0.620 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2018 | 24 | 0.610 |
Why?
| | Postural Balance | 5 | 2024 | 199 | 0.580 |
Why?
| | Bone Density | 3 | 2018 | 463 | 0.570 |
Why?
| | Hip | 3 | 2025 | 55 | 0.570 |
Why?
| | Cognitive Dysfunction | 1 | 2022 | 346 | 0.540 |
Why?
| | Adaptation, Physiological | 1 | 2020 | 514 | 0.510 |
Why?
| | Adult | 26 | 2025 | 35600 | 0.510 |
Why?
| | Behavior Therapy | 1 | 2018 | 241 | 0.490 |
Why?
| | Walking Speed | 1 | 2016 | 44 | 0.480 |
Why?
| | Adaptation, Psychological | 1 | 2020 | 617 | 0.470 |
Why?
| | Arthralgia | 1 | 2015 | 49 | 0.450 |
Why?
| | Peripheral Vascular Diseases | 1 | 2015 | 102 | 0.450 |
Why?
| | Autonomic Nervous System Diseases | 2 | 2025 | 34 | 0.450 |
Why?
| | Quadriceps Muscle | 4 | 2024 | 129 | 0.440 |
Why?
| | Patient Reported Outcome Measures | 3 | 2025 | 374 | 0.400 |
Why?
| | Diabetic Angiopathies | 3 | 2019 | 261 | 0.390 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2024 | 1365 | 0.350 |
Why?
| | Feasibility Studies | 4 | 2025 | 869 | 0.330 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 5415 | 0.320 |
Why?
| | Oxygen Consumption | 2 | 2025 | 672 | 0.300 |
Why?
| | Muscle Stretching Exercises | 1 | 2008 | 18 | 0.300 |
Why?
| | Ankle | 1 | 2008 | 62 | 0.290 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2018 | 2442 | 0.290 |
Why?
| | Disease Progression | 2 | 2015 | 2627 | 0.280 |
Why?
| | Dependent Ambulation | 2 | 2019 | 10 | 0.280 |
Why?
| | Quality of Life | 5 | 2025 | 2688 | 0.260 |
Why?
| | Phenotype | 1 | 2015 | 3075 | 0.260 |
Why?
| | Social Support | 2 | 2020 | 584 | 0.240 |
Why?
| | Patient Compliance | 3 | 2020 | 565 | 0.240 |
Why?
| | Kinetics | 2 | 2020 | 1645 | 0.240 |
Why?
| | Multimorbidity | 1 | 2025 | 46 | 0.230 |
Why?
| | Postoperative Period | 3 | 2024 | 330 | 0.220 |
Why?
| | Pain Measurement | 3 | 2025 | 508 | 0.220 |
Why?
| | Treatment Outcome | 9 | 2025 | 10219 | 0.220 |
Why?
| | Leg | 2 | 2016 | 239 | 0.210 |
Why?
| | Functional Laterality | 1 | 2024 | 222 | 0.210 |
Why?
| | Confidence Intervals | 2 | 2018 | 317 | 0.210 |
Why?
| | Pain | 2 | 2024 | 787 | 0.210 |
Why?
| | Patient Participation | 2 | 2024 | 414 | 0.210 |
Why?
| | Exercise Tolerance | 1 | 2025 | 273 | 0.200 |
Why?
| | Patient Satisfaction | 4 | 2021 | 633 | 0.200 |
Why?
| | Low Back Pain | 1 | 2024 | 106 | 0.190 |
Why?
| | Regional Blood Flow | 1 | 2024 | 463 | 0.190 |
Why?
| | Peripheral Arterial Disease | 2 | 2019 | 458 | 0.190 |
Why?
| | Cumulative Trauma Disorders | 1 | 2022 | 41 | 0.190 |
Why?
| | Stair Climbing | 1 | 2021 | 2 | 0.180 |
Why?
| | Reproducibility of Results | 4 | 2023 | 3080 | 0.180 |
Why?
| | Bone Density Conservation Agents | 2 | 2015 | 70 | 0.180 |
Why?
| | Evaluation Studies as Topic | 1 | 2020 | 175 | 0.170 |
Why?
| | Decision Support Techniques | 1 | 2024 | 398 | 0.170 |
Why?
| | Qualitative Research | 2 | 2024 | 1219 | 0.160 |
Why?
| | Cross-Over Studies | 2 | 2025 | 520 | 0.160 |
Why?
| | Case-Control Studies | 4 | 2019 | 3378 | 0.160 |
Why?
| | Retrospective Studies | 8 | 2024 | 14522 | 0.160 |
Why?
| | Task Performance and Analysis | 2 | 2011 | 173 | 0.160 |
Why?
| | Mammography | 1 | 2000 | 146 | 0.160 |
Why?
| | Proof of Concept Study | 1 | 2019 | 69 | 0.160 |
Why?
| | Wearable Electronic Devices | 1 | 2019 | 45 | 0.150 |
Why?
| | Sulfonylurea Compounds | 1 | 2018 | 46 | 0.150 |
Why?
| | Patient Discharge | 1 | 2025 | 836 | 0.150 |
Why?
| | Placebos | 1 | 2018 | 201 | 0.150 |
Why?
| | Double-Blind Method | 4 | 2019 | 1875 | 0.140 |
Why?
| | Heart Rate | 3 | 2025 | 802 | 0.140 |
Why?
| | High-Intensity Interval Training | 1 | 2018 | 24 | 0.140 |
Why?
| | Thiazolidinediones | 1 | 2018 | 137 | 0.140 |
Why?
| | Self-Assessment | 1 | 2018 | 70 | 0.140 |
Why?
| | Diet, Reducing | 1 | 1998 | 87 | 0.140 |
Why?
| | User-Computer Interface | 1 | 1998 | 147 | 0.140 |
Why?
| | Time Factors | 3 | 2024 | 6555 | 0.140 |
Why?
| | Cohort Studies | 3 | 2016 | 5426 | 0.140 |
Why?
| | Feedback | 1 | 2017 | 162 | 0.140 |
Why?
| | Psychometrics | 1 | 2021 | 696 | 0.130 |
Why?
| | Postmenopause | 1 | 1998 | 349 | 0.120 |
Why?
| | Ulna | 1 | 1996 | 27 | 0.120 |
Why?
| | Radius | 1 | 1996 | 36 | 0.120 |
Why?
| | Posture | 1 | 2017 | 175 | 0.120 |
Why?
| | Bone and Bones | 1 | 2018 | 294 | 0.120 |
Why?
| | Knee Prosthesis | 1 | 2015 | 18 | 0.120 |
Why?
| | Spine | 1 | 2017 | 160 | 0.120 |
Why?
| | Amputation, Traumatic | 1 | 2016 | 20 | 0.120 |
Why?
| | Perception | 1 | 2018 | 344 | 0.120 |
Why?
| | Acceleration | 1 | 2015 | 30 | 0.120 |
Why?
| | Calcitonin | 1 | 2015 | 27 | 0.120 |
Why?
| | Metformin | 1 | 2018 | 318 | 0.120 |
Why?
| | Research Design | 2 | 2020 | 1045 | 0.110 |
Why?
| | Radiography | 2 | 2015 | 797 | 0.110 |
Why?
| | Cognition Disorders | 1 | 1998 | 505 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2018 | 506 | 0.110 |
Why?
| | Computer Simulation | 1 | 1998 | 939 | 0.110 |
Why?
| | Psychomotor Performance | 1 | 2016 | 317 | 0.110 |
Why?
| | Motivation | 1 | 2018 | 547 | 0.110 |
Why?
| | Lumbar Vertebrae | 1 | 1996 | 234 | 0.110 |
Why?
| | Patient Safety | 1 | 2017 | 287 | 0.110 |
Why?
| | Torque | 1 | 2013 | 82 | 0.110 |
Why?
| | Brain Injuries | 1 | 1998 | 466 | 0.110 |
Why?
| | Statistics as Topic | 2 | 2009 | 305 | 0.100 |
Why?
| | Pilot Projects | 1 | 2018 | 1592 | 0.100 |
Why?
| | Mass Screening | 1 | 2000 | 1190 | 0.100 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2012 | 39 | 0.100 |
Why?
| | Thigh | 1 | 2012 | 53 | 0.100 |
Why?
| | Parathyroid Hormone | 1 | 2012 | 107 | 0.100 |
Why?
| | Proteins | 1 | 1998 | 944 | 0.100 |
Why?
| | Comorbidity | 1 | 2016 | 1547 | 0.090 |
Why?
| | Heart Failure | 1 | 2024 | 2133 | 0.090 |
Why?
| | Severity of Illness Index | 3 | 2021 | 2739 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 1280 | 0.080 |
Why?
| | Regression Analysis | 1 | 2012 | 997 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1221 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2012 | 693 | 0.080 |
Why?
| | Metatarsophalangeal Joint | 1 | 2008 | 11 | 0.070 |
Why?
| | United States | 2 | 2025 | 13871 | 0.070 |
Why?
| | Models, Biological | 1 | 2015 | 1724 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2000 | 2133 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 226 | 0.070 |
Why?
| | Incidence | 1 | 2015 | 2641 | 0.070 |
Why?
| | Etidronic Acid | 1 | 2007 | 5 | 0.070 |
Why?
| | Linear Models | 3 | 2013 | 819 | 0.070 |
Why?
| | Hepatitis C | 1 | 2010 | 243 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2006 | 0.070 |
Why?
| | Reference Values | 1 | 2008 | 794 | 0.070 |
Why?
| | Prognosis | 1 | 2015 | 3774 | 0.060 |
Why?
| | Body Mass Index | 1 | 2015 | 2274 | 0.060 |
Why?
| | Risk Factors | 3 | 2012 | 9786 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2008 | 1293 | 0.060 |
Why?
| | Obesity | 1 | 1998 | 2882 | 0.060 |
Why?
| | Foot | 1 | 2024 | 93 | 0.050 |
Why?
| | Antiparkinson Agents | 1 | 2022 | 28 | 0.050 |
Why?
| | Knee | 1 | 2023 | 63 | 0.050 |
Why?
| | Clinical Trials, Phase III as Topic | 1 | 2022 | 93 | 0.050 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2022 | 47 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2022 | 110 | 0.050 |
Why?
| | Goals | 1 | 2023 | 159 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 286 | 0.050 |
Why?
| | Prospective Studies | 2 | 2011 | 7135 | 0.040 |
Why?
| | Sampling Studies | 1 | 2000 | 96 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2000 | 115 | 0.040 |
Why?
| | Physical Examination | 1 | 2022 | 234 | 0.040 |
Why?
| | Community-Based Participatory Research | 1 | 2021 | 148 | 0.040 |
Why?
| | Health Maintenance Organizations | 1 | 2000 | 97 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2022 | 400 | 0.040 |
Why?
| | Needs Assessment | 1 | 2022 | 357 | 0.040 |
Why?
| | Focus Groups | 1 | 2022 | 450 | 0.040 |
Why?
| | Clinical Clerkship | 1 | 2000 | 96 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2018 | 110 | 0.040 |
Why?
| | Sex Hormone-Binding Globulin | 1 | 1998 | 53 | 0.040 |
Why?
| | Radioimmunoassay | 1 | 1998 | 175 | 0.040 |
Why?
| | Risk | 1 | 2000 | 855 | 0.040 |
Why?
| | Odds Ratio | 1 | 2000 | 1019 | 0.040 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 1998 | 84 | 0.040 |
Why?
| | Mobile Applications | 1 | 2020 | 161 | 0.030 |
Why?
| | Propensity Score | 1 | 2018 | 264 | 0.030 |
Why?
| | Self Report | 1 | 2021 | 799 | 0.030 |
Why?
| | Models, Statistical | 1 | 2000 | 625 | 0.030 |
Why?
| | Leptin | 1 | 1998 | 220 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 767 | 0.030 |
Why?
| | Students, Medical | 1 | 2000 | 322 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2018 | 1042 | 0.030 |
Why?
| | Physician-Patient Relations | 1 | 2000 | 540 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1198 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2000 | 1947 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 1996 | 248 | 0.030 |
Why?
| | Body Composition | 1 | 1998 | 649 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2016 | 546 | 0.030 |
Why?
| | Isometric Contraction | 1 | 2013 | 185 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2720 | 0.020 |
Why?
| | Laboratories, Hospital | 1 | 2010 | 14 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 419 | 0.020 |
Why?
| | Administration, Oral | 1 | 2012 | 787 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 834 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 515 | 0.020 |
Why?
| | Urban Health | 1 | 2010 | 79 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2012 | 1308 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1998 | 4894 | 0.020 |
Why?
| | Hepacivirus | 1 | 2010 | 239 | 0.020 |
Why?
| | Bone Resorption | 1 | 2007 | 80 | 0.020 |
Why?
| | Collagen Type I | 1 | 2007 | 118 | 0.020 |
Why?
| | Cartilage, Articular | 1 | 2007 | 292 | 0.010 |
Why?
| | Prevalence | 1 | 2010 | 2564 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2011 | 0.010 |
Why?
| | Peptides | 1 | 2007 | 926 | 0.010 |
Why?
| | Massachusetts | 1 | 2000 | 159 | 0.010 |
Why?
| | Teaching | 1 | 2000 | 217 | 0.010 |
Why?
| | Biomarkers | 1 | 2007 | 3968 | 0.010 |
Why?
| | Adolescent | 1 | 2010 | 20412 | 0.010 |
Why?
| | Primary Health Care | 1 | 2000 | 1686 | 0.010 |
Why?
|
|
Christiansen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|